FDA requirements for nonclinical testing of contraceptive steroids
- 1 December 1992
- journal article
- guideline
- Published by Elsevier in Contraception
- Vol. 46 (6) , 499-509
- https://doi.org/10.1016/0010-7824(92)90114-9
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthateJournal of Clinical Endocrinology & Metabolism, 1992
- Oral contraceptives and risk of breast cancerInternational Journal of Cancer, 1990
- Breast cancer and combined oral contraceptives: results from a multinational studyBritish Journal of Cancer, 1990
- Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer.BMJ, 1989
- Food and drug administration guidelines for reproductive toxicity testingReproductive Toxicology, 1988